^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SC-CAR4BRAIN
i
Other names: SC-CAR4BRAIN
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Seattle Children's Hospital
Drug class:
HER2-targeted CAR-T immunotherapy, B7-H3-targeted CAR-T immunotherapy, EGFR806-targeted CAR-T immunotherapy, IL-13Rα2-targeted CAR-T immunotherapy
Related drugs:
11ms
Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors (clinicaltrials.gov)
P1, N=72, Recruiting, Seattle Children's Hospital | Not yet recruiting --> Recruiting
Enrollment open • CAR T-Cell Therapy
|
EGFR806-specific CAR T-cell therapy • SC-CAR4BRAIN
Share via
